MLSS Milestone Scientific Inc

Price (delayed)

$0.868

Market cap

$67.03M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.1

Enterprise value

$63.4M

Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary ...

Highlights
The debt has contracted by 22% YoY and by 7% from the previous quarter
The company's gross margin rose by 18% YoY
The gross profit is up by 29% year-on-year but it has declined by 3.1% since the previous quarter
The revenue is up by 9% year-on-year but it is down by 3.5% since the previous quarter
The company's quick ratio fell by 46% YoY and by 24% QoQ
The equity has contracted by 21% YoY and by 7% from the previous quarter

Key stats

What are the main financial stats of MLSS
Market
Shares outstanding
77.23M
Market cap
$67.03M
Enterprise value
$63.4M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
8.91
Price to sales (P/S)
7.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.69
Earnings
Revenue
$9.48M
EBIT
-$7.23M
EBITDA
-$7.09M
Free cash flow
-$4.54M
Per share
EPS
-$0.1
Free cash flow per share
-$0.06
Book value per share
$0.1
Revenue per share
$0.12
TBVPS
$0.14
Balance sheet
Total assets
$11.35M
Total liabilities
$3.89M
Debt
$369,348
Equity
$7.46M
Working capital
$7.18M
Liquidity
Debt to equity
0.05
Current ratio
2.97
Quick ratio
1.56
Net debt/EBITDA
0.51
Margins
EBITDA margin
-74.8%
Gross margin
69.4%
Net margin
-74.5%
Operating margin
-76.3%
Efficiency
Return on assets
-63.5%
Return on equity
-92.1%
Return on invested capital
-149.1%
Return on capital employed
-93.8%
Return on sales
-76.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MLSS stock price

How has the Milestone Scientific stock price performed over time
Intraday
2.12%
1 week
-9.58%
1 month
29.55%
1 year
-21.8%
YTD
25.82%
QTD
27.65%

Financial performance

How have Milestone Scientific's revenue and profit performed over time
Revenue
$9.48M
Gross profit
$6.58M
Operating income
-$7.23M
Net income
-$7.06M
Gross margin
69.4%
Net margin
-74.5%
The gross profit is up by 29% year-on-year but it has declined by 3.1% since the previous quarter
The net margin has grown by 20% YoY but it has contracted by 6% from the previous quarter
The operating margin has increased by 20% year-on-year but it has declined by 6% since the previous quarter
The company's gross margin rose by 18% YoY

Growth

What is Milestone Scientific's growth rate over time

Valuation

What is Milestone Scientific stock price valuation
P/E
N/A
P/B
8.91
P/S
7.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.69
Milestone Scientific's EPS has increased by 9% YoY
The P/B is 39% lower than the 5-year quarterly average of 14.7 but 22% higher than the last 4 quarters average of 7.3
The equity has contracted by 21% YoY and by 7% from the previous quarter
The P/S is 37% less than the 5-year quarterly average of 11.5 but 24% more than the last 4 quarters average of 5.9
The revenue is up by 9% year-on-year but it is down by 3.5% since the previous quarter

Efficiency

How efficient is Milestone Scientific business performance
The company's return on invested capital rose by 36% YoY but it fell by 22% QoQ
The return on equity has declined by 25% year-on-year and by 9% since the previous quarter
Milestone Scientific's ROS has increased by 19% YoY but it has decreased by 6% from the previous quarter
MLSS's ROA is down by 13% YoY and by 3.9% QoQ

Dividends

What is MLSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MLSS.

Financial health

How did Milestone Scientific financials performed over time
The total assets is 192% greater than the total liabilities
The company's quick ratio fell by 46% YoY and by 24% QoQ
Milestone Scientific's current ratio has decreased by 32% YoY and by 15% from the previous quarter
The debt is 95% less than the equity
The debt has contracted by 22% YoY and by 7% from the previous quarter
The equity has contracted by 21% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.